TYK2 kinase inhibitors
US12187716B2 · kind B2 · utility
0Cited by
8References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 7, 2019 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | May 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D263/48
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compounds of the formula (1): or a salt or tautomer thereof, wherein R1 is hydrogen or fluorine, pharmaceutical compositions containing the compounds and medical uses of the compounds (for example, in the treatment of inflammatory or immune disorders).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.